Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Scheiman

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Family Practice|November 25, 2010
Which NSAID for your patient with osteoarthritis?James M Scheiman, David Sidote
Current Opinion in Gastroenterology|July 12, 2011
New diagnostic imaging modalities for pancreatic diseaseCyrus Piraka, James M Scheiman
Nature Clinical Practice. Gastroenterology & Hepatology|March 8, 2007
Is EUS-guided FNA biopsy the best diagnostic tool for lymphadenopathy of unknown origin?Richard Kwon, James M Scheiman
Postgraduate Medicine|February 9, 2018
Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesicsNicholas Moore, James M Scheiman
Gastrointestinal Endoscopy Clinics of North America|February 28, 2003
Nonmucinous cystic pancreatic neoplasmsMichelle A Anderson, James M Scheiman
Gastrointestinal Endoscopy|October 17, 2015
"Risky business": periprocedural aspirin use for colonoscopy with polypectomyMegan A Adams, James M Scheiman
The American Journal of Gastroenterology|July 4, 2013
Growth of ambulatory surgical centers, surgery volume, and savings to medicareJames M Scheiman, Jason A Dominitz
The American Journal of Gastroenterology|October 3, 2002
NSAIDs without a prescription: over-the-counter access, under-counted risksJames M Scheiman, A Mark Fendrick
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Informed choices in anti-inflammatory drug therapy: why patient risk mattersJames M Scheiman, A Mark Fendrick
Clinical Therapeutics|May 4, 2010
Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse eventsJames M Scheiman, Clemence E Hindley
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Family Practice|November 25, 2010
Which NSAID for your patient with osteoarthritis?James M Scheiman, David Sidote
Current Opinion in Gastroenterology|July 12, 2011
New diagnostic imaging modalities for pancreatic diseaseCyrus Piraka, James M Scheiman
Nature Clinical Practice. Gastroenterology & Hepatology|March 8, 2007
Is EUS-guided FNA biopsy the best diagnostic tool for lymphadenopathy of unknown origin?Richard Kwon, James M Scheiman
Postgraduate Medicine|February 9, 2018
Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesicsNicholas Moore, James M Scheiman
Gastrointestinal Endoscopy Clinics of North America|February 28, 2003
Nonmucinous cystic pancreatic neoplasmsMichelle A Anderson, James M Scheiman
Gastrointestinal Endoscopy|October 17, 2015
"Risky business": periprocedural aspirin use for colonoscopy with polypectomyMegan A Adams, James M Scheiman
The American Journal of Gastroenterology|July 4, 2013
Growth of ambulatory surgical centers, surgery volume, and savings to medicareJames M Scheiman, Jason A Dominitz
The American Journal of Gastroenterology|October 3, 2002
NSAIDs without a prescription: over-the-counter access, under-counted risksJames M Scheiman, A Mark Fendrick
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Informed choices in anti-inflammatory drug therapy: why patient risk mattersJames M Scheiman, A Mark Fendrick
Clinical Therapeutics|May 4, 2010
Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse eventsJames M Scheiman, Clemence E Hindley
Pageof 13